We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $157M Turnover 30.95%
1-Year Est. Return 60.08%
This Fund
S&P 500
This Quarter Est. Return
-6.85%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$109M
AUM Growth
-$10.1M
Cap. Flow
+$2.31M
Cap. Flow %
2.12%
Top 10 Hldgs %
38.45%
Holding
73
New
4
Increased
25
Reduced
5
Closed
10
Avg Time Held
1.8 years
Top 10 Avg Time Held
1.4 years
Top 20 Avg Time Held
1.4 years

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$1.88M
2
ARKO icon
ARKO Corp
ARKO
+$1.61M
3
BIDU icon
Baidu
BIDU
+$1.51M
4
THFF icon
First Financial Corp
THFF
+$955K
5
TALO icon
Talos Energy
TALO
+$935K

Top Sells

Rank Stock Value
1
AMSC icon
American Superconductor
AMSC
+$3.38M
2
RIGL icon
Rigel Pharmaceuticals
RIGL
+$2.96M
3
INCY icon
Incyte
INCY
+$1.71M
4
FHN icon
First Horizon
FHN
+$1.54M
5
TRC icon
Tejon Ranch
TRC
+$693K

Sector Composition

Rank Sector Weight
1 Healthcare 35.69%
2 Technology 11.09%
3 Materials 10.64%
4 Consumer Staples 8.17%
5 Consumer Discretionary 7.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
TGB
1
Trekor Metals
TGB
$3B
$6M 5.51%
2,450,000
-50,000
-2% -$127K
2020 Q4
14 quarters
ALCO icon
2
Alico
ALCO
$283M
$5.83M 5.35%
225,000
+10,000
+5% +$270K
2020 Q4
14 quarters
FOLD icon
3
DELISTED
Amicus Therapeutics
FOLD
$4.46M 4.1%
450,000
– –
2020 Q4
14 quarters
RLGT icon
4
Radiant Logistics
RLGT
$423M
$4.41M 4.05%
775,000
+50,000
+7% +$260K
2020 Q4
14 quarters
RPRX icon
5
Royalty Pharma
RPRX
$26.3B
$4.22M 3.87%
160,000
– –
2023 Q4
2 quarters
NMRK icon
6
Newmark Group
NMRK
$2.1B
$4.09M 3.75%
400,000
– –
2020 Q4
14 quarters
KD icon
7
Kyndryl
KD
$2.57B
$3.68M 3.38%
140,000
– –
2021 Q4
10 quarters
PLPC icon
8
Preformed Line Products
PLPC
$1.84B
$3.24M 2.97%
26,000
– –
2020 Q4
14 quarters
INTT icon
9
inTEST
INTT
$168M
$3.05M 2.8%
309,000
+84,000
+37% +$898K
2023 Q4
2 quarters
ARKO icon
10
ARKO Corp
ARKO
$453M
$2.91M 2.67%
1,020,000
+300,000
+42% +$1.61M
2021 Q1
13 quarters
PD icon
11
PagerDuty
PD
$1.31B
$2.75M 2.52%
120,000
– –
2023 Q2
4 quarters
BGC icon
12
BGC Group
BGC
$5.37B
$2.7M 2.48%
325,000
– –
2020 Q4
14 quarters
ARKR icon
13
Ark Restaurants
ARKR
$16.2M
$2.62M 2.41%
200,000
+15,393
+8% +$220K
2020 Q4
14 quarters
BIDU icon
14
Baidu
BIDU
$27.9B
$2.59M 2.38%
30,000
+15,000
+100% +$1.51M
2024 Q1
1 quarter
OGN icon
15
Organon & Co
OGN
$3.61B
$2.59M 2.37%
125,000
– –
2023 Q2
4 quarters
TALO icon
16
Talos Energy
TALO
$2.84B
$2.43M 2.23%
200,000
+75,000
+60% +$935K
2020 Q4
14 quarters
BABA icon
17
Alibaba
BABA
$277B
$2.16M 1.98%
30,000
+10,000
+50% +$767K
2024 Q1
1 quarter
VTRS icon
18
Viatris
VTRS
$20B
$2.13M 1.95%
200,000
– –
2020 Q4
14 quarters
B icon
19
Barrick Mining
B
$64B
$2.08M 1.91%
125,000
+45,000
+56% +$764K
2023 Q2
4 quarters
CLPT icon
20
ClearPoint Neuro
CLPT
$282M
$2.02M 1.85%
375,000
– –
2021 Q4
10 quarters
CGAU icon
21
Centerra Gold
CGAU
$4.12B
$2.02M 1.85%
300,000
+50,000
+20% +$328K
2023 Q4
2 quarters
IOVA icon
22
Iovance Biotherapeutics
IOVA
$6.44B
$2M 1.84%
250,000
– –
2023 Q3
3 quarters
CHRS icon
23
Coherus Oncology
CHRS
$162M
$1.9M 1.75%
1,100,000
+100,000
+10% +$201K
2020 Q4
14 quarters
RBCAA icon
24
Republic Bancorp
RBCAA
$1.78B
$1.88M 1.72%
35,000
+5,000
+17% +$255K
2020 Q4
14 quarters
WBA icon
25
DELISTED
Walgreens Boots Alliance
WBA
$1.81M 1.66%
150,000
+10,000
+7% +$170K
2023 Q3
3 quarters
1
2 3

Similar funds

SFSG
Sound Financial Strategies Group Madison, Mississippi $157M AUM 15.51% 1-Year Est. Return
PTFIS
Pekao Towarzystwo Funduszy Inwestycyjnych SA Warsaw $157M AUM
AWMG
ADG Wealth Management Group Metairie, Louisiana $158M AUM 18.25% 1-Year Est. Return
LDNAM
Lepercq De Neuflize Asset Management New York $158M AUM 20.61% 1-Year Est. Return
DFS
Demming Financial Services Aurora, Ohio $157M AUM
APW
Aurora Private Wealth Rockaway, New Jersey $158M AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
TC
Town Capital Bel Air, Maryland $158M AUM

CM Management's Q2 2024 Portfolio in Review

As of Q2 2024, CM Management held 73 positions worth $109M, down 8.5% from $119M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

CM Management's Q2 2024 filing shows 4 new, 25 increased, 5 reduced and 10 closed positions. Its largest new stake was CVS Health: 30,000 shares worth $1.77M. The largest sale was American Superconductor, an estimated $3.38M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 43% a quarter earlier, followed by Technology and Materials.

  • CM Management's largest Q2 2024 buy was CVS Health: 30,000 shares worth $1.77M.
  • CM Management added most to ARKO Corp in Q2 2024, an estimated $1.61M increase.
  • CM Management's biggest Q2 2024 reduction was Pan American Silver, cutting an estimated $493K.
  • CM Management fully exited American Superconductor in Q2 2024, selling an estimated $3.38M.
  • CM Management's ten largest holdings make up 38% of its $109M portfolio in Q2 2024.
  • CM Management opened 4 new positions and closed 10 in Q2 2024.
  • CM Management's portfolio value fell 8.5% quarter-over-quarter to $109M.

Based on CM Management's 13F filing for Q2 2024, filed 1 Aug 2024.